Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial

References

• Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208–2218.
   PubMed Web of Science ®Google Scholar
• Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005;16(6):1788–1793.
   PubMed Web of Science ®Google Scholar
• Isakova T, Xie H, Yang W, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305(23):2432–2439.
   PubMed Web of Science ®Google Scholar
• Scialla JJ, Xie H, Rahman M, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014;25(2):349–360.
   PubMed Web of Science ®Google Scholar
• Bricker NS. On the pathogenesis of the uremic state. An exposition of the “trade-off hypothesis”. N Engl J Med. 1972;286(20):1093–1099.
   PubMed Web of Science ®Google Scholar
• Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945–1953.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Yang JY, Luan CC, et al. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients. Clin Exp Nephrol. 2016;20(5):815–821.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Peng YS, Wu HY, et al. Accuracy of a nutrient database in estimating the dietary phosphorus-to-protein ratio and using a boiling method in low-phosphate hospital diets. Sci Rep. 2018;8(1):15246.
   PubMedGoogle Scholar
• Slatopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 1973;4(2):141–145.
   PubMed Web of Science ®Google Scholar
• Grabner A, Amaral AP, Schramm K, et al. Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab. 2015;22(6):1020–1032.
   PubMed Web of Science ®Google Scholar
• Finch JL, Lee DH, Liapis H, et al. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification. Kidney Int. 2013;84(6):1145–1153.
   PubMed Web of Science ®Google Scholar
• Thomas L, Bettoni C, Knopfel T, et al. Acute adaption to oral or intravenous phosphate requires parathyroid hormone. J Am Soc Nephrol. 2017;28(3):903–914.
   PubMed Web of Science ®Google Scholar
• Scanni R, vonRotz M, Jehle S, et al. The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol. 2014;25(12):2730–2739.
   PubMed Web of Science ®Google Scholar
• Burnett SM, Gunawardene SC, Bringhurst FR, et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21(8):1187–1196.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Wu HY, Peng YS, et al. Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018;33(11):1977–1983.
   PubMed Web of Science ®Google Scholar
• Isakova T, Gutierrez OM, Smith K, et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant. 2011;26(2):584–591.
   PubMed Web of Science ®Google Scholar
• Liu Z, Su G, Guo X, et al. Dietary interventions for mineral and bone disorder in people with chronic kidney disease. Cochrane Database Syst Rev. 2015;(9):Cd010350.
   Google Scholar
• Tsai WC, Wu HY, Peng YS, et al. Short-term effects of very-low-phosphate and low-phosphate diets on fibroblast growth factor 23 in hemodialysis patients: a randomized crossover trial. Clin J Am Soc Nephrol. 2019;14(10):1475–1483.
   PubMed Web of Science ®Google Scholar
• Hill Gallant KM. Dietary phosphorus and FGF23: is more restriction better? Clin J Am Soc Nephrol. 2019;14(10):1424–1426.
   PubMed Web of Science ®Google Scholar
• Zsom L, Zsom M, Abdul Salim S, et al. Subjective global assessment of nutrition, dialysis quality, and the theory of the scientific method in Nephrology practice. Artif Organs. 2020;44(10):1021–1030.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Finn WF, Emmett M, et al. The phosphate binder equivalent dose. Semin Dial. 2011;24(1):41–49.
   PubMed Web of Science ®Google Scholar
• Benoit K. Linear regression models with logarithmic transformations. Methodology Institute, London School of Economics; March 17, 2011; [cited 2020 Mar 10]. Available from:https://kenbenoit.net/assets/courses/ME104/logmodels2.pdf.
   Google Scholar
• Edmonston D, Wolf M. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol. 2020;16(1):7–19.
   PubMed Web of Science ®Google Scholar
• Combe C, Morel D, de Precigout V, et al. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol). Nephron. 1995;70(3):287–295.
   PubMed Web of Science ®Google Scholar
• Combe C, Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int. 1994;46(5):1381–1386.
   PubMed Web of Science ®Google Scholar
• Portale AA, Booth BE, Halloran BP, et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984;73(6):1580–1589.
   PubMed Web of Science ®Google Scholar
• Reiss E, Canterbury JM, Bercovitz MA, et al. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest. 1970;49(11):2146–2149.
   PubMed Web of Science ®Google Scholar
• Slatopolsky E, Caglar S, Gradowska L, et al. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake. Kidney Int. 1972;2(3):147–151.
   PubMed Web of Science ®Google Scholar
• Karkkainen M, Lamberg-Allardt C. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. J Bone Miner Res. 1996;11(12):1905–1912.
   PubMed Web of Science ®Google Scholar
• de Francisco AL, Cobo MA, Setien MA, et al. Effect of serum phosphate on parathyroid hormone secretion during hemodialysis. Kidney Int. 1998;54(6):2140–2145.
   PubMed Web of Science ®Google Scholar
• Slatopolsky E, Finch J, Denda M, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest. 1996;97(11):2534–2540.
   PubMed Web of Science ®Google Scholar